A monumental shift in leadership is set for this June, as Dr. Myron (Mike) Cohen, a towering figure in infectious disease research and the founding director of the Institute for Global Health and Infectious Diseases (IGHID), has announced he will be stepping down from his role. This transition
As the United States confronts a deeply concerning decline in national life expectancy driven by the relentless spread of chronic diseases, the Yale School of Public Health has made a pivotal leadership appointment aimed directly at the heart of this crisis. The selection of Dr. Magdalena Cerdá, a
With the official end of the COVID-19 pandemic declared over a year ago, many are moving on. Yet, a steady stream of research reveals a more complicated and concerning picture of the virus's long-term impact on our bodies and brains. To unpack these findings and what they mean for public health,
Two of the most feared health challenges facing humanity are the slow, irreversible loss of sight and the devastating decline of the mind, yet a new wave of research is targeting the root causes of these conditions with unprecedented ambition. Supported by prestigious innovation grants designed to
Today we're joined by James Maitland, a leading expert on the complex intersection of healthcare law, corporate accountability, and the pharmaceutical industry. He has spent decades analyzing how multinational corporations navigate legal systems and the profound impact their actions have on
The common observation that a cut on the cheek often vanishes while a similar injury on an arm leaves a permanent mark has long been a medical curiosity, but a groundbreaking study from Stanford Medicine has now unraveled the precise biological reasons for this phenomenon. By investigating the
